VialTalk
VialTalk
Double R Labs logo

Triple Agonist 10mg — Verification Report

From Double R Labs · Lot DRL-06-RT10 · Tested June 2026

← Back to Double R Labs
VialTalk
Verification report

Triple Agonist 10mg

Double R Labs

Score
108.7
Grade
A++
Superlative
Lot DRL-06-RT10
Tested June 2026
Report ID
b26cb262
PurityFull credit
HPLC
99.46%
IdentityFull credit
Mass spectrometry
Confirmed
ContentFull credit
Gravimetric vs label claim · tested weight disclosed and verified
10 mg labeled · 11.37 mg tested
EndotoxinFull credit
USP <85> compendial
Screened
Heavy metalsFull credit
USP <232>/<233> compendial
Screened
SterilityFull credit
USP <71> compendial
Screened
Batch conformityStrong
Three-to-four vial average
Assessed
Additional screens, not scoredFentanyl screen

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →